ALX ONCOLOGY HOLDINGS INC
Company Stats
- Market Cap
- $192.2M
- as of Sep 30, 2026
- Shares Outstanding
- 138.3M
- Free Float
- 72.7%
Income Statement
- Operating Income
- -$104.0M
- Net Income
- -$101.7M
- EBITDA
- -$103.3M
- Non-cash Impairment
- $3.2M
Cash Flow
- Free Cash Flow
- -$84.4M
- FCF Yield
- -43.9%
- Owner FCF Yield
- -50.4%
Balance Sheet
- Cash & Equivalents
- $16.4M
Returns & Capital
- SBC, 3Y Avg
- $22.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$84.4M | — |
| FY2024 | — | -$122.4M | — |
| FY2023 | — | -$131.6M | — |
| FY2022 | $0 | -$90.7M | — |
| FY2021 | $0 | -$68.8M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 5, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back